Mission dermatology Center

Rancho Santa Margarita, California 92688

3 studies enrolling now · 10 studies all time

What they study most

Active Nonsegmental Vitiligo, Cancer, Cutaneous Melanoma, DEB - Dystrophic Epidermolysis Bullosa, Dominant Dystrophic Epidermolysis Bullosa, Dystrophic Epidermolysis Bullosa, Generalized Epidermolysis Bullosa Simplex, Melanoma Stage III, Melanoma Stage IV, Netherton Syndrome, Plaque Psoriasis, Recessive Dystrophic Epidermolysis Bullosa

Studies at this site

• A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa — Recruiting now
• A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors — Recruiting now
• Long-Term Follow-up Protocol — Recruiting now
• An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS) — Running, not enrolling
• Natural History of Netherton Syndrome — Stopped early
• A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2 — Running, not enrolling
• Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects — Running, not enrolling
• A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome — Stopped early
• A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa — Completed
• Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB — Completed